Table 1.
Cohort | Age | Gender | p16 Mutation Status | Melanoma Diagnosis |
---|---|---|---|---|
A1 | 37 | M | 377T>A (p.V126D) | N |
A2 | 40 | M | 377T>A (p.V126D) | N |
A3 | 37 | M | 377T>A (p.V126D)) | N |
A4 | 46 | M | 377T>A (p.V126D) | N |
A5 | 64 | F | 377T>A (p.V126D) | N |
B1 | 86 | M | 377T>A (p.V126D) | Y |
B2 | 56 | M | 377T>A (p.V126D) | Y |
B3 | 83 | M | 377T>A (p.V126D) | Y |
B4 | 66 | F | 377T>A (p.V126D) | Y |
B5 | 50 | M | 377T>A (p.V126D) | Y |
B6 | 39 | F | 377T>A (p.V126D) | Y |
B7 | 42 | F | 377T>A (p.V126D) | Y |
B8 | 52 | F | 377T>A (p.V126D) | Y |
C1 | 68 | M | negative | N |
C2 | 40 | F | negative | N |
C3 | 41 | M | negative | N |
C4 | 46 | M | negative | N |
C5 | 45 | F | negative | N |
C6 | 36 | M | negative | N |
C7 | 58 | M | negative | N |
C8 | 63 | M | negative | N |
C9 | 88 | M | negative | N |
C10 | 34 | F | negative | N |
C11 | 36 | F | negative | N |
C12 | 40 | F | negative | N |
C13 | 68 | F | negative | N |
D1 | 50 | M | Not tested | met mel |
D2 | 48 | F | Not tested | met mel |
D3 | 38 | M | Not tested | met mel |
D4 | 55 | M | Not tested | met mel |
D5 | 34 | M | Not tested | met mel |
D6 | 81 | M | Not tested | met mel |
D7 | 82 | F | Not tested | met mel |
D8 | 40 | M | Not tested | met mel |
D9 | 40 | M | Not tested | met mel |
D10 | 55 | M | Not tested | met mel |